India · English
Natco Pharma to invest $14 mn in US-based biotechnology firm eGenesis Inc
Natco Pharma plans to invest $14 million in US biotech firm eGenesis Inc in 2024, following an $8 million investment made through preferred stock in the same year.
Read the full report at Business Standard →
About this page
AKHBAARI groups the same story across publishers so you can see who is reporting it and how they differ. The summary above is machine-generated from the publisher's own feed text and is labelled as such. The full report stays with the publisher, who holds copyright in it. See our editorial policy.